143 related articles for article (PubMed ID: 9400375)
1. Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Circ Res; 1997 Dec; 81(6):953-62. PubMed ID: 9400375
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose.
Yasunari K; Kohno M; Kano H; Yokokawa K; Minami M; Yoshikawa J
Circulation; 1999 Mar; 99(10):1370-8. PubMed ID: 10077523
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law RE; Meehan WP; Xi XP; Graf K; Wuthrich DA; Coats W; Faxon D; Hsueh WA
J Clin Invest; 1996 Oct; 98(8):1897-905. PubMed ID: 8878442
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone improves blood flow by inhibiting neointimal formation after balloon injury in Otsuka Long-Evans Tokushima fatty rats.
Min KM; Park SW; Cho KY; Song MS; Kim DK; Park GS; Lee MK
Metabolism; 2002 Aug; 51(8):998-1002. PubMed ID: 12145772
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone inhibits alpha1-adrenoceptor-induced DNA synthesis in vascular smooth muscle cells.
Nishio E; Watanabe Y
Eur J Pharmacol; 1999 Jun; 374(1):127-35. PubMed ID: 10422649
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions.
Little PJ; Osman N; de Dios ST; Cemerlang N; Ballinger M; Nigro J
Cardiovasc Diabetol; 2007 Oct; 6():33. PubMed ID: 17963526
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells.
Kihara S; Ouchi N; Funahashi T; Shinohara E; Tamura R; Yamashita S; Matsuzawa Y
Atherosclerosis; 1998 Jan; 136(1):163-8. PubMed ID: 9544743
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose.
Yasunari K; Kohno M; Kano H; Minami M; Yoshikawa J
Hypertension; 2000 May; 35(5):1092-8. PubMed ID: 10818070
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.
Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y
Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells.
Graf K; Xi XP; Hsueh WA; Law RE
FEBS Lett; 1997 Jan; 400(1):119-21. PubMed ID: 9000525
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells.
de Dios ST; Hannan KM; Dilley RJ; Hill MA; Little PJ
J Diabetes Complications; 2001; 15(3):120-7. PubMed ID: 11358680
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.
Song J; Walsh MF; Igwe R; Ram JL; Barazi M; Dominguez LJ; Sowers JR
Diabetes; 1997 Apr; 46(4):659-64. PubMed ID: 9075808
[TBL] [Abstract][Full Text] [Related]
16. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes.
Morikang E; Benson SC; Kurtz TW; Pershadsingh HA
Am J Hypertens; 1997 Apr; 10(4 Pt 1):440-6. PubMed ID: 9128211
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone enhances glycolysis and improves intracellular glucose metabolism in rat mesangial cells.
Asano T; Wakisaka M; Yoshinari M; Nakamura S; Doi Y; Fujishima M
Metabolism; 2000 Mar; 49(3):308-13. PubMed ID: 10726906
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.
Gouni-Berthold I; Berthold HK; Weber AA; Seul C; Vetter H; Sachinidis A
Exp Clin Endocrinol Diabetes; 2001; 109(4):203-9. PubMed ID: 11453032
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone induces GLUT4 translocation in L6 myotubes.
Yonemitsu S; Nishimura H; Shintani M; Inoue R; Yamamoto Y; Masuzaki H; Ogawa Y; Hosoda K; Inoue G; Hayashi T; Nakao K
Diabetes; 2001 May; 50(5):1093-101. PubMed ID: 11334413
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats.
Shinohara E; Kihara S; Ouchi N; Funahashi T; Nakamura T; Yamashita S; Kameda-Takemura K; Matsuzawa Y
Atherosclerosis; 1998 Feb; 136(2):275-9. PubMed ID: 9543098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
